G1 Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Perry Andrew
G1 Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer MURDOCK TERRY L
G1 Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Bailey John E. (Jack) Jr.
G1 Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Malik Rajesh
G1 Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Umstead John W. V
G1 Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Avagliano Mark
G1 Therapeutics | 10-Q: Quarterly report
G1 Therapeutics | 8-K: Current report
G1 Therapeutics | ARS: Annual Report to Security Holders
G1 Therapeutics | DEF 14A: Definitive information statements
G1 Therapeutics | DEFA14A: Others
G1 Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition
G1 Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
G1 Therapeutics | 8-K: Current report
G1 Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Avagliano Mark
G1 Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Thomas Monica R.
G1 Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Umstead John W. V
G1 Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Umstead John W. V
G1 Therapeutics | 10-K: Annual report
G1 Therapeutics | 8-K: Current report
No Data